nialamide has been researched along with Erythroblastosis Fetalis in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwiatkowska, E | 1 |
1 other study available for nialamide and Erythroblastosis Fetalis
| Article | Year |
|---|---|
[Prevention and treatment of mental disorders in children after neonatal hemolytic disease].
Topics: Child; Child, Preschool; Erythroblastosis, Fetal; Female; Humans; Mental Disorders; Nialamide; Pregn | 1966 |